
Limpen M 1mg/500mg Tablet SR
Marketer
Limbson Pharmaceuticals LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Limpen M 1mg/500mg Tablet SR
Diabeva Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabeva Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Commonly, Diabeva Duo can cause hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, and tremors—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (sugary foods or fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires prior medical consultation. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function as advised by your doctor.
Primary Ingredients of Limpen M 1mg/500mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Limpen M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Limpen M 1mg/500mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume Limpen M 1mg/500mg Extended-Release Tablet with food.
Common Side effects of Limpen M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Limpen M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Limpen M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.
How Limpen M 1mg/500mg Tablet SR works:
Limpen M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Limpen M 1mg/500mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Limpen M 1mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Extended-release Limpen M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with kidney impairment, the extended-release Limpen M 1mg/500mg tablet requires careful administration, potentially necessitating dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Consult your physician before use.
LiverCAUTION
For individuals with liver impairment, the use of Limpen M 1mg/500mg Tablet SR requires careful consideration. Dosage modification of Limpen M 1mg/500mg Tablet SR may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver disease, Limpen M 1mg/500mg Tablet SR is typically initiated at a reduced dosage; however, its administration is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Limpen M 1mg/500mg Tablet SR :
Should you forget a Limpen M 1mg/500mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Limpen M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
